Start your Weight Loss Journey today!

BOOK FREE CONSULTATION

Weight Loss with Tirzepatide

Tirzepatide is a once-weekly injectable medication that has been shown to be highly effective for weight management in individuals with obesity or who are overweight and have related health conditions. It works by mimicking two natural gut hormones—GLP-1 and GIP—that regulate appetite, digestion, and blood sugar. By slowing the emptying of food from the stomach, improving how the body uses insulin, and signaling fullness to the brain, tirzepatide helps reduce appetite and caloric intake, making it easier to lose weight and maintain results.

Clinical studies have shown that tirzepatide can lead to significant, sustained weight loss when combined with healthy lifestyle changes. While not a stimulant or traditional diet medication, tirzepatide supports long-term metabolic health by targeting the root causes of weight gain.

How Does Tirzepatide Work for Weight Loss?

  • Reduces appetite and cravings: It signals the brain that you’re full, which helps lower food intake.

  • Slows stomach emptying: Food stays in the stomach longer, leading to increased feelings of fullness after eating.

  • Improves how the body handles sugar and fat: By enhancing insulin sensitivity and lowering blood sugar swings, it helps stabilize energy levels and reduce fat storage.

BOOK FREE CONSULTATION
Tirzepatide Bedford MA mounjaro weight loss

 FAQs

  • Most people lose 15–25% of their starting body weight over about 1–1.5 years at higher doses (10–15 mg weekly)

  • Tirzepatide is administered as a subcutaneous injection (under the skin) once a week, using a insulin syringe. It can be injected in the abdomen, thigh, or upper arm.

  • Common side effects include:

    Nausea

    Vomiting

    Diarrhea

    Constipation

    Abdominal pain

    These side effects often decrease as your body adjusts to the medication.

  • Tirzepatide is not recommended for individuals with:

    A personal or family history of medullary thyroid carcinoma

    Multiple Endocrine Neoplasia syndrome type 2

    Severe gastrointestinal disease

    Known allergy to semaglutide or any of its components